PKB

On election eve, all 3 of Indonesia’s presidential candidates have troubling human rights records

Retrieved on: 
Martedì, Febbraio 13, 2024

After nearly three months of campaigning, the three pairs vying for presidential and vice presidential seats are now in the cooling-off period.

Key Points: 
  • After nearly three months of campaigning, the three pairs vying for presidential and vice presidential seats are now in the cooling-off period.
  • That past is why the commitments of candidates to resolve human rights violations always come up during Indonesian elections.

Anies: concerns about his backers

  • Their programs related to human rights underlines Anies’ pledges to strengthen national human rights institutions, resolve past human rights cases and provide socio-economic recovery for victims of human rights violations.
  • Anies is the candidate with the most comprehensive details on his plans to revise regulations hindering press freedom and civil liberties.

Prabowo: haunted by deadly human rights allegations

  • Frontrunner Prabowo Subianto, who is running with President Joko “Jokowi” Widodo’s eldest son Gibran Rakabuming Raka, has pledged to strengthen democracy by protecting human rights for citizens.
  • The pair have also promised to eliminate discriminatory practices, including protecting the fundamental rights of communities and vulnerable groups.
  • However, only Prabowo-Gibran have not included any program to resolve past human rights violations among all candidates.

Ganjar: unresolved agrarian disputes

  • However, they do not expressly state what kinds of programs they will have to achieve this.
  • Ganjar has a poor record on agrarian conflicts during his tenure as the former governor of Central Java.
  • In 2018, he issued an environmental permit to construct the Bener Dam in Purworejo, Central Java, as part of a mining site.

No candidate is clean

  • The three presidential and vice-presidential pairs and their supporters have yet to be entirely assertive on the issue of civil liberties and human rights protection.
  • Given their track records, Indonesian voters face a challenge to vote for the candidate with the clearest position on human rights issues, given no one is thoroughly “clean” from human rights controversies.


Eka Nugraha Putra tidak bekerja, menjadi konsultan, memiliki saham, atau menerima dana dari perusahaan atau organisasi mana pun yang akan mengambil untung dari artikel ini, dan telah mengungkapkan bahwa ia tidak memiliki afiliasi selain yang telah disebut di atas.

Third Success from Astex Drug Discovery Pharma Collaboration and Licence Agreements as AstraZeneca Receives US Marketing Approval for Cancer Drug Truqap (capivasertib)

Retrieved on: 
Lunedì, Novembre 20, 2023

CAMBRIDGE, United Kingdom, Nov. 20, 2023 (GLOBE NEWSWIRE) -- Astex Pharmaceuticals (UK), a pharmaceutical company dedicated to the discovery and development of novel small molecule therapeutics for oncology and diseases of the central nervous system, announced today that it is in line to receive a milestone payment from AstraZeneca on first commercial sale of the drug in the US and royalties from AstraZeneca on future sales following the US Food and Drug Administration’s (FDA) approval of Truqap™ plus Faslodex® as a treatment for adult patients with HR-positive, HER2-negative locally advanced or metastatic breast cancer with one or more biomarker alterations (PIK3CA, AKT1 or PTEN). Eligible patients will have progressed on at least one endocrine-based regimen in the metastatic setting or experienced recurrence on or within 12 months of completing adjuvant therapy.

Key Points: 
  • This is the third cancer drug in the last five years to reach market approval that has been discovered and developed under, or subsequent to, an Astex drug discovery collaboration.
  • Truqap was discovered by AstraZeneca following an earlier drug discovery research collaboration between Astex, The Institute of Cancer Research, London, and Cancer Research Technology (CRT; now Cancer Research Horizons) that was signed in 2003.
  • In 2010, AstraZeneca announced its discovery of Truqap, and began to develop the drug as a potential treatment for various forms of cancer.
  • This is also a great example of UK Biotech-Academia-Pharma collaboration and underlines the strength of the UK life sciences ecosystem.”
    Graphic of the hat-trick of three marketed cancer drugs discovered and developed under, or subsequent to, an Astex drug discovery collaboration with pharma

CGO Legal Release Step-By-Step Guide on How to Complete a Successful Company Registration in Poland

Retrieved on: 
Martedì, Ottobre 24, 2023

Warsaw, Poland, Oct. 24, 2023 (GLOBE NEWSWIRE) -- CGO Legal, a leading law firm in Warsaw, Poland, that provides complex support in the fields of business establishment, is excited to announce it has released a comprehensive step-by-step guide on how to complete a successful company registration poland .

Key Points: 
  • Warsaw, Poland, Oct. 24, 2023 (GLOBE NEWSWIRE) -- CGO Legal, a leading law firm in Warsaw, Poland, that provides complex support in the fields of business establishment, is excited to announce it has released a comprehensive step-by-step guide on how to complete a successful company registration poland .
  • Utilising CGO Legal’s 13 years of experience opening companies in Poland, the law firm has created the all-inclusive resource to demystify the company registration process, highlight the most important aspects of business registration in Poland and showcase the benefits of a company’s formation in Poland.
  • The standardised step-by-step guide to complete company formation poland provided by CGO Legal contains the following process:
    The shareholders or their legal representatives sign the statute of the Polish limited liability company documents.
  • As a result of registration, the company will get a “KRS number” (visible in the Polish business register).

Unihertz's Latest QWERTY Smartphone Raised 400K+ USD on Kickstarter in 12 Hours

Retrieved on: 
Mercoledì, Maggio 11, 2022

HONG KONG, May 11, 2022 /PRNewswire/ -- Unihertz has just launched the company's third and latest smartphone of its QWERTY series, Titan Slim, a sleek and neat physical keyboard smartphone which has already raised over $400,000.

Key Points: 
  • HONG KONG, May 11, 2022 /PRNewswire/ -- Unihertz has just launched the company's third and latest smartphone of its QWERTY series, Titan Slim, a sleek and neat physical keyboard smartphone which has already raised over $400,000.
  • Unihertz's Titan series may not be ideal for everyone, it's good to see that someone is still working on it.
  • Later, the company brought back small rugged smartphones and revived QWERTY keyboard phones that were equipped with the latest Android technology, all with great triumphs.
  • This year marks the company's fifth-year anniversary on Kickstarter, and it proudly presents its latest project, Titan Slim.

Unihertz's Latest QWERTY Smartphone Raised 400K+ USD on Kickstarter in 12 Hours

Retrieved on: 
Mercoledì, Maggio 11, 2022

HONG KONG, May 11, 2022 /PRNewswire/ -- Unihertz has just launched the company's third and latest smartphone of its QWERTY series, Titan Slim, a sleek and neat physical keyboard smartphone which has already raised over $400,000.

Key Points: 
  • HONG KONG, May 11, 2022 /PRNewswire/ -- Unihertz has just launched the company's third and latest smartphone of its QWERTY series, Titan Slim, a sleek and neat physical keyboard smartphone which has already raised over $400,000.
  • Unihertz's Titan series may not be ideal for everyone, it's good to see that someone is still working on it.
  • Later, the company brought back small rugged smartphones and revived QWERTY keyboard phones that were equipped with the latest Android technology, all with great triumphs.
  • This year marks the company's fifth-year anniversary on Kickstarter, and it proudly presents its latest project, Titan Slim.

Current Health Partners with Patients Know Best to Provide Unprecedented Real-Time Visibility of Patient Data

Retrieved on: 
Giovedì, Giugno 6, 2019

Current Health and Patients Know Best (PKB) today announced an integrated solution that lets clinicians and care teams monitor vital signs and health information in real-time.

Key Points: 
  • Current Health and Patients Know Best (PKB) today announced an integrated solution that lets clinicians and care teams monitor vital signs and health information in real-time.
  • Patients Know Best collects patient data from healthcare providers and shares it quickly, safely and effectively, giving patients, carers and their care teams immediate access to vital information and support anywhere, anytime.
  • Mohammad Al-Ubaydli, CEO and Founder of Patients Know Best, added, The BMJ1 and others have long highlighted the importance of informing patients and relatives in real-time about the progress of an acute illness.
  • Patients Know Best (PKB) is the UKs largest patient portal and the worlds first patient-controlled health records system.